
Publications | Makromolecular Therapeutics Group Prof. Dr. Lutz Nuhn
Journal Article (9)
1.
Journal Article
9, 1760 (2018)
The Protein Corona as a Confounding variable of nanoparticle-Mediated Targeted vaccine Delivery. Frontiers in immunology 2.
Journal Article
289, pp. 125 - 145 (2018)
Immunoengineering through cancer vaccines - A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 3.
Journal Article
29 (7), pp. 2394 - 2405 (2018)
Targeting Protumoral Tumor-Associated Macrophages with Nanobody-Functionalized Nanogels through Strain Promoted Azide Alkyne Cycloaddition Ligation. Bioconjugate Chemistry 4.
Journal Article
30 (45), 1803397 (2018)
Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses. Advanced Materials 5.
Journal Article
57 (33), pp. 10760 - 10764 (2018)
FRET Monitoring of Intracellular Ketal Hydrolysis in Synthetic Nanoparticles. Angewandte Chemie International Edition 6.
Journal Article
178, pp. 643 - 651 (2018)
Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Biomaterials 7.
Journal Article
30 (23), pp. 8587 - 8596 (2018)
pH-Sensitive Hydrazone-Linked Doxorubicin Nanogels via Polymeric-Activated Ester Scaffolds: Synthesis, Assembly, and In Vitro and In Vivo Evaluation in Tumor-Bearing Zebrafish. Chemistry of Materials 8.
Journal Article
140 (43), pp. 14300 - 14307 (2018)
Lymph-Node-Targeted Immune Activation by Engineered Block Copolymer Amphiphiles-TLR7/8 Agonist Conjugates. Journal of the American Chemical Society 9.
Journal Article
29 (3), pp. 748 - 760 (2018)
Transiently Thermoresponsive Acetal Polymers for Safe and Effective Administration of Amphotericin B as a Vaccine Adjuvant. Bioconjugate Chemistry